|1||Enrolling by invitation||
Study of Zoledronic Acid, Pravastatin, and Lonafarnib for Patients With Progeria
Clinical Studies of Progeria
Phase I/II Trial of Everolimus in Combination With Lonafarnib in Progeria
A Study of Zoledronic Acid, Pravastatin, and Lonafarnib for Patients With Progeria
Phase II Trial of Lonafarnib (a Farnesyltransferase Inhibitor) for Progeria
Treatment of the Hutchinson-Gilford Progeria Syndrome With a Combination of Pravastatin and Zoledronic Acid
† Study has passed its completion date and status has not been verified in more than two years.